M. Heppt

P04.02 Diversity of CD4+ blood T-cell clonality predicts longer survival with CTLA4 or PD-1 checkpoint inhibition in advanced melanoma

C. Berking, A. Galinski, J. Tietze, 2021, Journal for ImmunoTherapy of Cancer.

Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial).

K. Kähler, A. Bohne, L. Heinzerling, 2023, Journal of cancer research and clinical oncology.

Immune checkpoint inhibition and targeted therapy for melanoma: A patient‐oriented cross‐sectional comparative multicentre study

S. Haferkamp, M. Gaiser, R. Gutzmer, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Successful treatment of lichen amyloidosus with oral alitretinoin

M. Flaig, J. Tietze, M. Heppt, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.